Amundi lowered its position in shares of Cognex Co. (NASDAQ:CGNX – Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 69,181 shares of the scientific and technical instruments company’s stock after selling 5,350 shares during the quarter. Amundi’s holdings in Cognex were worth $2,594,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Advisors Asset Management Inc. grew its holdings in shares of Cognex by 123.1% during the 3rd quarter. Advisors Asset Management Inc. now owns 714 shares of the scientific and technical instruments company’s stock worth $29,000 after purchasing an additional 394 shares during the period. SBI Securities Co. Ltd. purchased a new stake in shares of Cognex during the 4th quarter worth about $29,000. SRS Capital Advisors Inc. lifted its position in Cognex by 50.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 885 shares of the scientific and technical instruments company’s stock worth $32,000 after acquiring an additional 295 shares in the last quarter. Truvestments Capital LLC acquired a new position in Cognex during the 3rd quarter worth approximately $36,000. Finally, Clean Yield Group lifted its position in Cognex by 1,686.7% during the 4th quarter. Clean Yield Group now owns 1,072 shares of the scientific and technical instruments company’s stock worth $38,000 after acquiring an additional 1,012 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.
Insider Transactions at Cognex
In related news, EVP Carl Gerst sold 6,803 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $32.73, for a total transaction of $222,662.19. Following the completion of the transaction, the executive vice president now owns 4,566 shares of the company’s stock, valued at $149,445.18. This trade represents a 59.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 1.10% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Report on CGNX
Cognex Trading Up 4.1 %
CGNX stock opened at $31.51 on Monday. The firm has a market cap of $5.35 billion, a P/E ratio of 51.66 and a beta of 1.43. Cognex Co. has a 12-month low of $30.04 and a 12-month high of $53.13. The stock’s 50 day simple moving average is $36.18 and its 200 day simple moving average is $38.04.
Cognex (NASDAQ:CGNX – Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The scientific and technical instruments company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). Cognex had a return on equity of 5.65% and a net margin of 11.61%. On average, research analysts forecast that Cognex Co. will post 0.61 EPS for the current fiscal year.
Cognex Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Thursday, February 27th were paid a dividend of $0.08 per share. The ex-dividend date was Thursday, February 27th. This represents a $0.32 dividend on an annualized basis and a yield of 1.02%. Cognex’s payout ratio is currently 52.46%.
About Cognex
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Read More
- Five stocks we like better than Cognex
- What Are the U.K. Market Holidays? How to Invest and Trade
- How to Build the Ultimate Everything ETF Portfolio
- What Makes a Stock a Good Dividend Stock?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Stocks With High ROE and Market-Beating Growth Potential
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.